Mochida Pharmaceutical Co., Ltd.
Important Dates
Mochida Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 9, 2026.
| Earnings Date | 11/9/2026 |
Share Statistics
As of March 31, 2026, Mochida Pharmaceutical Co., Ltd. has 35.45M shares outstanding.
| Shares Outstanding | 35.45M |
Financial Position
As of March 31, 2026, Mochida Pharmaceutical Co., Ltd. maintains a current ratio of 4.29, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.29 |
| Quick Ratio | 1.12 |
| Debt / Equity | 7.13 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1,500.75 |
Balance Sheet
EURAs of March 31, 2026, Mochida Pharmaceutical Co., Ltd. holds 169.31M in cash and equivalents against 54.52M in total debt, resulting in a net debt position of -98.48M. Total book value stands at 765.01M, with working capital of 497.67M providing operational flexibility.
| Cash & Cash Equivalents | 169.31M |
| Total Debt | 54.52M |
| Net Debt | -98.48M |
| Equity (Book Value) | 765.01M |
| Book Value Per Share | 21.58 |
| Working Capital | 497.67M |
Stock Splits
Mochida Pharmaceutical Co., Ltd.'s most recent stock split took place on March 27, 2019 with a 1:2 split ratio.
| Last Split Date | 3/27/2019 |
| Split Ratio | 1:2 |